Loading stock data…
Astrana Health Inc. (ASTH)
$38.10-0.37 (-0.96%)
After Hours$38.10+0.00 (+0.00%)· Last close Sep 8
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Astrana Health, Inc. in the Healthcare sector is trading at $38.10 with a market capitalization of $1.9B. Wall Street consensus targets $51.50 (8 analysts), implying a +35.2% move over the next 12 months. The stock is currently 26% below its 52-week high of $51.60, remaining 21.1% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +35.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $965.10M↑ | $950.53M↓ | $956.05M↑ | $654.81M |
| Gross Profit | — | $105.74M↑ | $95.04M↓ | $97.19M↑ | $77.97M |
| Operating Income | — | $28.53M↑ | $18.39M↓ | $19.21M↓ | $20.34M |
| Net Income | — | $14.44M↑ | $6.00M↑ | $373,000↓ | $9.42M |
Peer Comparison
JNJUNHPFE
Fundamentals
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.91B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
46.91
Beta
Defensive asset. Lower volatility than the S&P 500.
0.91
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.60%
Volume
Today's trading volume
304,589
Recent News
Here’s What Boosted Astrana Health (ASTH) in Q2
Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here. The strategy returned 24.01% in the second quarter, outperforming the Russell 2000 Index’s 21.49% return. Performance was positively affected by stock selection in health care and industrials, while the Fund’s underweight […]
2 Stocks Under $50 on Our Watchlist and 1 That Underwhelm
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call
Astrana Health’s second quarter was met with a positive market response, as management highlighted several drivers behind the results. The company saw continued demand from payer and provider partners, maturation of value-based care cohorts, and disciplined medical cost trend management. CEO Brandon Sim attributed operating leverage improvements to the company’s proprietary AI-native healthcare operating system, which has enabled more efficient workflows and reduced general and administrative ex
Astrana Health (ASTH) Q2 2026 Earnings Call Transcript
Revenue jumped 49% to $972.5 million as adjusted EPS hit record $0.80.
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook
Healthcare services company Astrana Health missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million. Next quarter’s revenue guidance of $1.02 billion underwhelmed, coming in 1.1% below analysts’ estimates. Its non-GAAP profit of $0.80 per share was 9.6% above analysts’ consensus estimates.